The rise of Sildenafil initially sparked a boom for pharma, however recent changes present a uncertain scenario for investors. Lower-cost competitors are eating into revenue, and persistent patent challenges add more https://zaynmsku077439.luwebs.com/42092226/sildenafil-and-pharma-a-precarious-bet